Harborside


IM Cannabis Corp.

CNSX: IMCC


Canadian symbol: IMCC.CN
US symbol: IMCC

Currency in CAD

Valuation Measures4

Market Cap (intraday) 38.04M
Enterprise Value 68.20M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.43
Price/Book (mrq)0.21
Enterprise Value/Revenue 0.83
Enterprise Value/EBITDA -2.04

Trading Information

Stock Price History

Beta (5Y Monthly) 2.19
52-Week Change 3-88.54%
S&P500 52-Week Change 3-16.88%
52 Week High 36.0000
52 Week Low 30.4400
50-Day Moving Average 30.6514
200-Day Moving Average 31.9219

Share Statistics

Avg Vol (3 month) 321.72k
Avg Vol (10 day) 325.33k
Shares Outstanding 574.58M
Implied Shares Outstanding 6N/A
Float 849.15M
% Held by Insiders 129.55%
% Held by Institutions 113.13%
Shares Short (Aug 14, 2022) 4115.89k
Short Ratio (Aug 14, 2022) 46.06
Short % of Float (Aug 14, 2022) 4N/A
Short % of Shares Outstanding (Aug 14, 2022) 40.17%
Shares Short (prior month Jul 14, 2022) 421.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Feb 11, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -55.93%
Operating Margin (ttm)-52.14%

Management Effectiveness

Return on Assets (ttm)-11.71%
Return on Equity (ttm)-29.62%

Income Statement

Revenue (ttm)81.81M
Revenue Per Share (ttm)1.17
Quarterly Revenue Growth (yoy)114.40%
Gross Profit (ttm)10.3M
EBITDA -36.64M
Net Income Avi to Common (ttm)-45.76M
Diluted EPS (ttm)-0.7580
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.86M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)36.02M
Total Debt/Equity (mrq)20.07
Current Ratio (mrq)1.18
Book Value Per Share (mrq)2.55

Cash Flow Statement

Operating Cash Flow (ttm)-22.29M
Levered Free Cash Flow (ttm)-21.28M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate-0.06-0.04-0.530.02
Low Estimate-0.06-0.04-0.530.02
High Estimate-0.06-0.04-0.530.02
Year Ago EPS-0.06-0.21-0.31-0.53
Revenue EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate25.3M27.3M100M137.5M
Low Estimate25.3M27.3M100M137.5M
High Estimate25.3M27.3M100M137.5M
Year Ago Sales18.75M8.3M54.3M100M
Sales Growth (year/est)34.90%228.90%84.20%37.50%
Earnings History2021-09-292021-12-302022-03-302022-06-29
EPS Est.-0.02-0.04-0.010.05
EPS Actual-0.06-0.21-0.14-0.3
Difference-0.04-0.17-0.13-0.35
Surprise %-200.00%-425.00%-1,300.00%-700.00%
EPS TrendCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.06-0.04-0.530.02
7 Days Ago-0.06-0.04-0.530.02
30 Days Ago-0.06-0.04-0.530.02
60 Days Ago0.060.070.170.38
90 Days Ago0.060.070.170.38
EPS RevisionsCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesIMCC.CNIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.81.00%N/AN/AN/A
Current Year-71.00%N/AN/AN/A
Next Year103.80%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
29.55%% of Shares Held by All Insider
13.13%% of Shares Held by Institutions
18.64%% of Float Held by Institutions
34Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Wasatch Advisors Inc3,539,452Jun 29, 20224.75%1,805,120
Mirae Asset Global Investments Co., Ltd.1,524,435Jun 29, 20222.04%777,461
Harrison (K.J.) & Partners, Inc.1,160,196Jun 29, 20221.56%591,699
AdvisorShares Investments, LLC987,142Jun 29, 20221.32%503,442
Murchinson Ltd.767,644Jun 29, 20221.03%391,498
Bank of Montreal/Can/434,965Jun 29, 20220.58%221,832
Baader Bank Inc 235,000Mar 30, 20220.34%119,849
Baader Bank Aktiengesellschaft235,000Jun 29, 20220.32%119,849
Royal Bank of Canada215,068Jun 29, 20220.29%109,684
EMC Capital Management128,997Jun 29, 20220.17%65,788
Susquehanna International Group, LLP45,152Jun 29, 20220.06%23,027

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
Wasatch Microcap Fund3,539,452Jun 29, 20224.75%1,805,120
Global X Fds-The Global X Cannabis ETF1,524,435Jul 30, 20222.04%777,461
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1,103,366Aug 30, 20221.48%562,716
Amplify Seymour Cannabis ETF93,000Apr 29, 20220.12%47,429
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by IM Cannabis Corp.


SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to Israel

SNDL and IM Cannabis Complete SNDL’s First International Export of Premium Dried Flower from Canada to Israel

CALGARY, AB and GLIL YAM, Israel, Sept. 15, 2022 - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company"), Canada's largest regulated products platform, and IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) ("IMC"), today announced that SNDL has completed its initial international export of approximately 167 kilograms of premium dried flower from ... Read More...
IM Cannabis Closes First Tranche of Non-Brokered Private Placement of Common Shares

IM Cannabis Closes First Tranche of Non-Brokered Private Placement of Common Shares

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO and GLIL YAM, Israel, Aug. 24, 2022 - IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, is pl... Read More...
IM Cannabis Announces USD$5,000,000 Private Placement Led by Management

IM Cannabis Announces USD$5,000,000 Private Placement Led by Management

TORONTO, ONTARIO, Canada and GLIL YAM, Israel, Aug. 19, 2022 -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, is pleased to announce that it is undertaking a non-brokered private placement for aggr... Read More...
IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

Gross margin of 24%, which is expected to increase with further asset integration, product availability, and operational improvements Approximately $6.5 million per year in expected cash cost savings from streamlining operations in Canada and closure of Israeli cultivation farm TORONTO and GLIL YAM, Israel, Aug. 15, 2022 -- IM Cannabis C... Read More...
IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

TORONTO and GLIL YAM, Israel, Aug. 4, 2022 -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the second quarter ended June 30, 2022, on Monday, Augu... Read More...
IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

Gross Profit Increased 37% from Q1 2021 as Operational Efficiencies from Integration Take Hold; Company Expects to Achieve Positive Adjusted EBITDA in Q2 2022 TORONTO and GLIL YAM, Israel, May 12, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational can... Read More...
IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

Closure of Sde Avraham farm in Israel optimizes Company's organizational structure by fully leveraging global import-export supply chain Increase in Revolving Credit Facility availability to $15 million supports increased global demand for premium cannabis TORONTO, Canada and GLIL YAM, Israel , April 6, 2022 -- IM Cannabis Corp. (the "Com... Read More...
IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

- Fiscal Year 2021 revenues increased 242% year-over-year to a record of over $54 million - Q4 2021 revenues increased 309% year-over-year and 39% compared to Q3 2021 - Sequential revenue growth and gross margin improvement expected in Q1 2022 TORONTO, and GLIL YAM, Israel, March 31, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabi... Read More...
IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy

IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem’s Leading Medical Cannabis Pharmacy

Transaction expands IMC's footprint into Israel's largest city while positioning the Company as one of the largest retailers of medical cannabis in the country TORONTO, and GLIL YAM, Israel, March 30, 2022 -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabi... Read More...
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

TORONTO and GLIL YAM, Israel, March 10, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, provided preliminary unaudited financial results for the three months and fiscal year ended Dec... Read More...
IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor rela... Read More...
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

IM Cannabis announces Focus Medical’s Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

The successful import demonstrates the strength of the IM Cannabis global supply chain and business modelTORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Can... Read More...
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company's Israeli Subsidiary

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 13, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMC... Read More...
IM Cannabis to Launch WAGNERS Brand in Germany

IM Cannabis to Launch WAGNERS Brand in Germany

IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis marketTORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE / December 7, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a global cannabis company with operations ... Read More...
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"),... Read More...
IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process

IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 26, 2021/ IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company has received confirmation from The Depository Trust Company ("DTC") that its... Read More...
IM Cannabis to Acquire Trichome in Landmark Transaction - Establishes Global Growth Platform and Leading Multi-Country Operator

IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator

Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating directly in Israel, the EU, and Canada, with forecast adjusted EBITDA profitability in 2021 IMC will leverage Trichome's premium indoor cultivation to meet growing demand for premium cannabis from ... Read More...
IM Cannabis Reports 57% Sequential Increase in Consolidated Revenues, Reaches Positive Adjusted EBITDA for Q3 2020

IM Cannabis Reports 57% Sequential Increase in Consolidated Revenues, Reaches Positive Adjusted EBITDA for Q3 2020

Consolidated revenues increased to $5.9 million in Q3 2020, a 57% sequential increase, while realizing gross margin before fair value impacts of 57%The Company reached positive adjusted EBITDA of $0.3 millionNASDAQ listing process progressing with expected listing early 2021* Currency is in CAD$ unless specified otherwiseTORONTO, ON and G... Read More...
IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

Shipments made to seven distribution partners in GermanyGerman operations and growing sales by Focus Medical create inflection point to positive adjusted EBITDA profitability beginning in September 2020IMC Netherlands has submitted its application to the Dutch government's controlled cannabis supply chain experiment* Currency is in CAD$ u... Read More...
IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

IMC has now completed shipments of its branded flower products to four of the Company's ten distribution partners, marking IMC's official brand launch in GermanyThree additional purchase commitments executed with German distributorsIMC now has binding purchase commitments for 1,615kg of medical cannabis* Currency is in CAD$ unless specifi... Read More...
IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling purchase commitments for IMC-branded productsAdjupharm adds Cansativa, Ilios and Farmako to its distribution network, platform now includes ten distributors* Currency is in CAD$ unless specified otherwiseTORONTO, GLIL YAM, Israel and ... Read More...
IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior year, a 62% increase, and a 180% increase over Q1 2020Gross margin before fair value impacts was 54% in Q2 2020Q2 2020 milestones include:* Currency is in CAD$ unless specified otherwiseTORONTO and GLIL YAM, Israel, Aug. 26, 2020 - IM Cannabis Corp. ... Read More...
Boost by Kaplan Teams Up with Find Your Grind to Inspire and Help Pre-College Students Chart their Education and Career Paths

Boost by Kaplan Teams Up with Find Your Grind to Inspire and Help Pre-College Students Chart their Education and Career Paths

Boost by Kaplan, an innovative online program designed to help pre-college students learn what careers look like and the skills needed to succeed in them, is working with Find Your Grind to deliver a highly engaging approach to learning and navigating the path to self-discovery and success. Find Your Grind offers an extensive library of m... Read More...
Boost by Kaplan Partners with The Myers–Briggs Company to Help Students Assess How Their Interests Can Translate to Increased College Readiness and Career Success

Boost by Kaplan Partners with The Myers–Briggs Company to Help Students Assess How Their Interests Can Translate to Increased College Readiness and Career Success

Boost by Kaplan, an innovative online program designed to provide pre-college age students with an invaluable career exploration experience to accelerate college and career readiness, has partnered with world-renowned assessment organization The Myers-Briggs Company to provide students with personal insights to help them decide on their e... Read More...
IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel

IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel

Focus Medical has entered into a supply agreement with Israeli-based Ever Green for a potential term of up to ten years Focus Medical will purchase all medical cannabis produced by Ever Green from its 86,000 square foot facility in Moshav Sgula, Israel Supply is secured for the six previously announced binding sales agreements between ... Read More...
Boost by Kaplan Collaborates with Google to Give High School Graduates Insights into Working in Business and Technology

Boost by Kaplan Collaborates with Google to Give High School Graduates Insights into Working in Business and Technology

Boost by Kaplan, an innovative online booster program designed to provide pre-college age students with an invaluable career exploration experience to accelerate college and career readiness, has collaborated with Google to provide insights about what it’s like in the real world of work, the importance of high demand jobs and skill sets, ... Read More...
IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners

IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners

IMC continues execution of German strategy with seven distribution agreements signed, adding axicorp, canymed and Materia Now a total of 1,525kg of sales secured under binding purchase commitments in Germany in the next twelve months All products to be sold under the IMC brand* Currency is in CAD$ unless specified otherwiseTORONTO, GLIL Y... Read More...
IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH

IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH

IMC delivering on German strategy with fourth binding purchase commitment with distribution partner in Germany Zur Rose Pharma GmbH is part of the Zur Rose Group – Europe's largest e-commerce pharmacy * Currency is in CAD$ unless specified otherwise TORONTO, GLIL YAM, Israel and BAD OLDESLOE, Germany, July 15, 2020 - IM Cannabis Corp. ... Read More...
IMC Reports Exercise of Warrants and Options

IMC Reports Exercise of Warrants and Options

Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives * Currency is in CAD$ unless specified otherwise TORONTO and GLIL YAM, Israel, June 30, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, annou... Read More...
IMC Announces Focus Medical's First Import from Canada to Israel, Strengthening International Network

IMC Announces Focus Medical’s First Import from Canada to Israel, Strengthening International Network

Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a global medical cannabis brand Focus Medical has successfully imported approximately 200kg of medical cannabis from Canada, now seven suppliers cultivating under IMC brand across Israel, Spain and Canada IMC brand well positioned for Isra... Read More...
The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

Kaplan Inc., a premier provider of educational programs and services, has teamed up with Hexco, Inc., DBA Hexco Academic, to co-host a national online spelling bee during the week of July 26, 2020. The bee will provide an opportunity for the nation’s top spellers to compete online, giving priority to eighth-grade students who were schedul... Read More...
IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

New generation of evidence-based cannabis products to be launched in IsraelIMC to be exclusive distributor of CannEpil® in Israel for five-year termCannEpil® was developed by MGC Pharma for the treatment of refractory epilepsy* Currency is in CAD$ unless specified otherwiseTORONTO and GLIL YAM, Israel , June 15, 2020 - IM Cannabis Corp. (... Read More...
IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

TORONTO and GLIL YAM, Israel, May 27, 2020  /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) announces that filing of the Company's interim financial statements for the three month period ended March 31, 2020 (the "Q1 Financial Statements") and associated management's discussion and analysis (the "Q1 MD&A", and collective... Read More...
IMC Announces Focus Medical's Successful Import of Medical Cannabis from Spain to Israel

IMC Announces Focus Medical’s Successful Import of Medical Cannabis from Spain to Israel

Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The medical cannabis was supplied by Linneo Health, the Company's strategic supply partner in Spain and an EU-GMP global supplier of medicinal cannabis Six suppliers now cultivating medical cannabis to Focus Medical for sale under the... Read More...
IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

Executing on long-term strategy to build distribution platform across the large German market Sales commitment for 465kg of IMC-branded medical cannabis over the next twelve months Together with other announced binding purchase agreements in Germany, a total of 825kg of IMC-branded medical cannabis is committed for sale over the next tw... Read More...
IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg of medical cannabis between 2020 and 2023 Focus Medical has now secured all the supply required under the six binding pharmacy sales agreements it has signed In 2020, Focus Medical signed binding sales agreements for pharmacies to purchase 33,075kg in medi... Read More...
IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

* Currency is in CAD$ unless specified otherwise PharmYarok entered into a three-year binding sales agreement with Focus Medical for 12,600kg of medical cannabis under the IMC brand PharmYarok to distribute IMC-branded product through its retail pharmacy and its leading e-commerce platform Binding sales agreements signed by Focus Medi... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,348.290.01%Negative
FTSE 1006,963.840.78%Negative
Nikkei 22526,431.552.66%Negative

Delayed data (1h)
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,348.290.01%Negative
FTSE 1006,963.840.78%Negative
Nikkei 22526,431.552.66%Negative


Share this page